SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas Roadster reveal, featuring cold-gas thrusters and brief aerial stunts, is driving attention; enthusiasts praise it as an engineering showcase, while skeptics question its practicality, road legality, and commercial value. Traders are also speculating about closer TeslaSpaceX ties, but merger claims remain unconfirmed.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Teslas Roadster reveal featuring SpaceX thruster technology is driving attention, with traders praising the engineering and speculating about closer TeslaSpaceX ties or a merger. Others dismiss the event as a publicity stunt, question its commercial value, and remain cautious amid SPCXs volatile trading.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is centered on anticipation for full Phase 3 melanoma-vaccine results at ESMO, building on an earlier positive topline readout and Goldman Sachs increased price target. Bulls view the personalized cancer-vaccine program as validation of the oncology pipeline, while skeptics say the surge has outrun fundamentals and warn of a potential sell-the-news pullback.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Hot inflation readings and Fed Chair Warshs comments on the rate path are fueling volatile trading, with traders split between viewing the rebound as a durable dip-buying move and a temporary bounce amid rate-hike concerns and AI-sector weakness.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencells sharp move has traders speculating about a repeat of its past meme-stock surge, citing its history of extreme volatility and claims that concentrated insider ownership could leave a limited tradable float and fuel a short squeeze. Others call the move a speculative pump-and-dump and warn about the companys weak fundamentals and lack of a clear new catalyst.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Firefly is drawing attention amid a broad selloff in space and other high-growth stocks, with traders citing inflation and interest-rate concerns alongside sector weakness. The debate centers on dip-buying and long-term NASA/space business prospects versus worries about continued downside, profitability, and launch execution.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras staggered IPO lockup expirations and the resulting fear of newly eligible shares being sold dominate discussion amid a steep decline. Traders disagree over whether unlock-related selling is driving the weakness or whether it reflects a broader AI and semiconductor selloff, while bears also question the companys valuation and reliance on OpenAI and bulls point to demand for its inference technology.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas move to a fresh record high following BMO Capitals bullish upgrade and improved outlook for consumer spending and value-added services is driving attention. Traders largely celebrate the breakout, though some warn the stock may be overextended and due for a pullback.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

BTDR is drawing attention after a steep selloff and weak performance versus other miners, with traders often blaming the announced at-the-market share offering and fearing further dilution. The debate pits concerns about dilution, debt and losses against bullish views of Bitdeers Bitcoin-mining scale and AI/data-center contracts, while some traders point to broader crypto-sector weakness.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnsons Q3 results are driving discussion: despite adjusted earnings beating expectations and a higher full-year outlook, shares sold off as sluggish MedTech growth and litigation-related charges weighed on sentiment. Traders are split between viewing the drop as a buying opportunity and worrying that weak device sales and legal overhangs could keep the stock under pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Infectious disease biotech Alopexx nearly triples offering size ahead of $33 million IPO $ALPX  $IPO #IPO https://zpr.io/PPHU3ufbg3QU

Alopexx, a Phase 2 biotech developing immune therapies for bacterial, fungal, and parasitic infections, raised the proposed deal size for its upcoming IPO on Friday.The Cambridge, MA-based company now plans to raise $33 million by offering 3 million shares at a price range of $10 to $12.

Renaissance Capital

ALPX IPO News - Infectious disease biotech Alopexx nearly triples offering size ahead of $33 million IPO

Zapier

Alopexx Inc

Renaissance Capital Greenwich Funds - Renaissance IPO ETF

Infectious disease biotech Alopexx nearly triples offering size ahead of $33 million IPO 